Skip to main content
. 2022 May 31;13:892512. doi: 10.3389/fimmu.2022.892512

Figure 4.

Figure 4

Establishment and verification of the nomogram. (A) The predictive nomogram built in combination with the risk signature and clinical characterization predicted three- and five-year survival rates of patients with CRC. OS and PFS prediction for CRC patients in TCGA data set, and OS and RFS prediction for CRC patients in the GSE39582 data set. (B) The probabilities of OS, PFS, and RFS at three and five years were assessed by calibration plots of the nomogram in TCGA and GSE39582. (C) ROC curves of the nomograms compared with those of other clinical variables with regard to three- and five-year survival in TCGA and GSE39582. OS, overall survival; PFS, progression-free survival; RFS, relapse-free survival.